Amgen still hopes new cardiovascular data will solve a problem facing cholesterol drug, Repatha – in almost eight out of ten cases US insurers and Medicare initially refuse to prescribe the drug. One ...
The deals tout significant discounts for people who pay out of pocket for certain medications. But most people with insurance ...
TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts ...
Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will sell ...
Amgen is committed to reducing drug costs, expanding its AmgenNow program, and investing in US manufacturing to gain tariff ...
For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...
It would take an act of Congress to officially rename the historic music venue, despite the Trump-appointed board’s decision.
President Trump’s anti-LGBTQ agenda dominated national news in 2025, particularly his cruel attacks on trans Americans. Here are our picks for the top 10 LGBTQ news stories the Blade covered in 2025.
The Daily Overview on MSN
9 pharma giants strike deals with Trump to cut drug prices
President Donald Trump has locked in a sweeping set of pricing agreements with nine of the world's biggest drugmakers, promising to pull some of the most expensive medicines on the U.S. market closer ...
Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha (evolocumab) ...
A new government-run discount medicine website is set to launch this month. It's called TrumpRx: A direct-to-consumer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback